ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2,1,Serum ferritin abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3,1,Brain malformation,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
3,2,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
5,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
6,1,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
7,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,2,Porphyria acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
8,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
8,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
10,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
12,1,Injection site thrombosis,Injection site reactions,Administration site reactions,Genrl,N
12,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
13,1,Injection site thrombosis,Injection site reactions,Administration site reactions,Genrl,N
14,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
15,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
16,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
17,1,Complication of device removal,Complications associated with device NEC,Complications associated with device,Genrl,N
17,2,Complication of device removal,Complications associated with device NEC,Complications associated with device,Genrl,N
17,3,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
17,4,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
18,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
19,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
21,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
21,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
21,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
22,1,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
22,2,Transferrin saturation increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
23,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
23,3,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
23,4,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
24,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
24,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
24,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
25,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
25,2,Iron overload,Iron excess,Iron and trace metal metabolism disorders,Metab,N
25,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
25,4,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
25,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
26,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
26,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
26,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
27,1,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
27,2,Liver iron concentration increased,Hepatobiliary histopathology procedures,Hepatobiliary investigations,Inv,N
27,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
28,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
28,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
29,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
29,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
29,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
